A New Perspective on mRNA Folding: Rethinking RNA Delivery Through Structure and Thermodynamics

Introduction: Are We Missing the Most Important Piece?

Over the past few years, mRNA therapeutics has rapidly expanded—from vaccines to cancer immunotherapy, gene editing, and protein replacement.

But if you’ve actually worked in this space, you’ve probably had this intuition:

Often, it’s not that your design isn’t good enough—it’s that delivery just doesn’t work.

So we optimize:

• Codon usage

• Nucleoside modifications

• Cap and poly(A) tail

• LNP formulations

All of these matter. But fundamentally, they operate within the same framework:

👉 We are optimizing mRNA as a sequence.

This recent Nature Nanotechnology paper challenges that assumption:

mRNA is not just a sequence—it has a shape.

A Simple but Powerful Idea: Fold the mRNA

This study introduces a strategy called:

Metal-ion-assisted RNA folding (MARF)

Instead of modifying the sequence or lipid composition, they:

👉 Use metal ions to induce mRNA folding into a compact 3D structure

The results are striking:

• Up to 7.3-fold increase in protein expression 

• Improved in vivo performance

• Enhanced CRISPR editing efficiency

At first glance, this looks like another delivery optimization.

But it’s actually pointing to something deeper.

mRNA Structure: We’ve Only Been Seeing Half of It

RNA structure exists at three levels:

• Primary: nucleotide sequence

• Secondary: hairpins, stem-loops

• Tertiary: global 3D folding

Most engineering efforts focus on secondary structure.

Tertiary structure, on the other hand, has largely been ignored—mainly because:

👉 It’s difficult to control and even harder to predict.

What this paper does is quite bold:

It uses metal ions to force mRNA into a folded state

Why Does This Work? A Thermodynamic Perspective

One of the most important (and often overlooked) aspects of this work is:

👉 It explains mRNA folding through thermodynamics

The data show:

• ΔH is negative (exothermic)

• ΔG is negative (spontaneous)

• Mn²⁺ has the strongest binding affinity (lowest Kd) 

So what does this mean?

An Intuitive Way to Think About It

mRNA is a negatively charged polymer:

👉 The phosphate backbone repels itself

👉 So it tends to stay in an extended conformation

When metal ions are introduced:

• They neutralize charge

• They provide stabilizing interactions

In other words:

👉 They lower the energetic cost of folding

Put simply:

Folding isn’t impossible—it’s just energetically expensive.

Metal ions reduce that barrier.

What Actually Changes Structurally?

AFM imaging shows:

• Linear mRNA: ~110 nm

• Folded mRNA: ~65 nm, thicker 

You can think of it as:

👉 A line → a compact sphere

The Real Turning Point: The LNP Changes

Here’s where things get interesting:

mRNA folding doesn’t just affect RNA—it changes the entire nanoparticle

Increased LNP Rigidity

• Young’s modulus increases by 2–4× 

Why?

👉 Folded RNA acts as an internal scaffold

Why Does That Matter for Delivery?

This brings us into something rarely discussed in RNA therapeutics:

👉 Mechanics

Soft vs. Rigid Nanoparticles

Soft (conventional LNPs)

• Easily deform

• Less efficient during membrane interaction

Rigid (MARF LNPs)

• Maintain structure

• More efficient uptake via endocytosis

📈 Experimental Results

• Uptake increases (up to ~4.8×) 

• Intracellular processing improves

Interestingly:

• Translation efficiency → no significant change

• mRNA stability → no major change

📌 Key takeaway:

This is not a “better translation” story—it’s a “more delivery” story.

In Vivo: Another Important Insight

One particularly interesting observation:

👉 Rigid LNPs stay longer in the liver

• 10.3 hr vs 1.1 hr 

What This Tells Us

Many delivery problems are not about:

👉 Failing to reach the target

But rather:

👉 Being cleared too quickly

CRISPR: Functional Validation

Using MARF LNPs:

• Pcsk9 editing improves

• Blood lipid levels decrease

• Single-dose effect lasts for weeks

This is critical because:

It demonstrates real therapeutic impact—not just in vitro improvement.

My Take: What This Paper Is Really Saying

1️⃣ mRNA is becoming a “material,” not just a sequence

Future design may shift toward:

👉 Structure, not just sequence

2️⃣ The payload affects the nanoparticle

Traditionally, we focus on lipids:

• SM-102

• MC3

• Helper lipids

But this work shows:

What’s inside the particle also determines its behavior

3️⃣ Mechanobiology is entering RNA therapeutics

This is probably the most important shift.

From Technology to Strategy: What We Do at LuTra Studio

If you zoom out, this paper reflects a broader industry trend:

RNA therapeutics is no longer a single-discipline problem.

You’re dealing with:

• Molecular design (mRNA structure)

• Materials science (LNP mechanics)

• Cell biology (uptake and trafficking)

• In vivo behavior (PK/PD)

Many teams get stuck in similar ways:

• Delivery doesn’t scale

• In vitro and in vivo don’t match

• No clear direction for optimization

At LuTra Studio, what we focus on is simple:

👉 Connecting these layers

We help with:

• mRNA and LNP design strategy

• Evaluating emerging technologies (like MARF)

• Aligning R&D direction with business positioning

📌 In one sentence:

Not helping you run more experiments—but helping you run the right ones.

What Still Needs to Be Solved

There are still open questions:

• Long-term safety of metal ions

• Reduced uptake in aging cells

• Tissue specificity

These will be critical for translation.

Final Thoughts

If I had to summarize this paper in one line:

mRNA is not just information—it’s a physical structure that can be engineered.

Once you start thinking in terms of:

sequence → structure → mechanics

many previously confusing problems start to make sense.

References

1. Yang B. et al. Rational design of rigid mRNA folding architecture to enhance intracellular processing and protein production. Nature Nanotechnology. 2026.

2. Leppek K. et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nature Communications. 2022.

3. Zhang H. et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023.

4. Miao L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nature Communications. 2020.